Related Experiment Video
Updated: May 18, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Evan's syndrome revisited
Priti Dave1, Kavita Krishna, A G Diwan
1Department of Medicine, Bharati Vidyapeeth University Medical College and Hospital, Pune 411001, Maharashtra.
The Journal of the Association of Physicians of India
|October 4, 2012
Summary
A 43-year-old female presented with severe bleeding and low platelets, initially responding to treatment. Tragically, she developed neurological symptoms and died, with investigations revealing Evan's syndrome.
Area of Science:
- Hematology
- Immunology
- Internal Medicine
Background:
- Evan's syndrome is a rare autoimmune disorder characterized by concurrent Idiopathic Thrombocytopenia Purpura (ITP) and Autoimmune Haemolytic Anaemia (AIHA).
- Early diagnosis and prompt management are crucial for improving patient outcomes in Evan's syndrome.
Observation:
- A 43-year-old female presented with acute per vaginal bleeding, severe thrombocytopenia, and anemia.
- Initial treatment with platelet and blood transfusions provided only partial response.
- The patient subsequently developed epistaxis, bleeding from access sites, and right-sided hemiparesis.
Findings:
- Investigations revealed findings consistent with both ITP and AIHA.
- The clinical presentation and laboratory findings led to a diagnosis of Evan's syndrome.
- The patient experienced a fatal outcome despite initial supportive care.
Implications:
- This case highlights the aggressive nature and potential severity of Evan's syndrome.
- It underscores the importance of recognizing overlapping autoimmune hematological conditions.
- Timely and aggressive immunosuppressive therapy may be critical in managing this life-threatening condition.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:43Sex Linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
01:43Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...